<DOC>
	<DOCNO>NCT00501852</DOCNO>
	<brief_summary>This study ass efficacy safety glycopyrronium bromide ( NVA237 ) patient stable COPD , comparison active comparator .</brief_summary>
	<brief_title>Efficacy Safety Four Doses Glycopyrronium Bromide ( NVA237 ) Patients With Stable Chronic Obstructive Pulmonary Disease ( COPD ) , Comparison Active Comparator Tiotropium</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Male female adult age ≥40 year , sign Informed Consent Form prior initiation studyrelated procedure . Patients moderate severe COPD accord Gold Guidelines ( 2006 ) . Patients smoke history least 10 pack year . Ten packyears define 20 cigarette day 10 year , 10 cigarette day 20 year etc . Patients postbronchodilator force expiratory volume 1 second ( FEV1 ) ≥30 % &lt; 80 % predict normal , postbronchodilator FEV1/forced vital capacity ( FVC ) &lt; 0.7 Visit 2 . For nonJapanese patient predict FEV1 calculate accord Quanjer predictive equation [ Quanjer PH 1993 ] , Japanese patient predict FEV1 calculate accord Japanese Respiratory Society predictive table [ Japan Respiratory Society 2001 ] . Pregnant woman nurse mother ( pregnancy confirm positive urine pregnancy test ) . Patients require oxygen therapy daily basis chronic hypoxemia , hospitalize exacerbation airways disease 6 week prior Visit 1 Visit 1 Visit 3 . Patients respiratory tract infection within 6 week prior Visit 1 . Patients develop respiratory tract infection screen period ( Visit 3 ) must discontinue trial , permit reenroll later date ( least 6 week resolution respiratory tract infection ) . Patients , judgment investigator responsible Novartis personnel , clinically relevant laboratory abnormality clinically significant condition ( limited ) unstable ischemic heart disease , cancer , leave ventricular failure , long term prednisone therapy , history myocardial infarction , arrhythmia ( ) , narrow angle glaucoma , symptomatic prostatic hyperplasia bladderneck obstruction moderate severe renal impairment . Patients history asthma indicate ( limited ) : 1 . Blood eosinophil count &gt; 400/mm3 2 . Onset symptom prior age 40 year . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>COPD , Age≥40 yr , Glycopyrronium Bromide</keyword>
</DOC>